UNASSIGNED: Impact of tissue @entity880 accumulation on prognosis after @entity583 ( @entity583 ) is biased. The study aimed to assess the prognostic role of @entity880 concentration (LC) in @entity1 with @entity583 during one year of follow-up. 145 consecutive @entity1 admitted due to @entity583 were enrolled. The data on the frequency of endpoint occurrence (defined as I, @entity204 ; II, @entity712 ( @entity712 ); and III, recurrent @entity583 (re-MI)) were collected. The @entity1 were divided into group A (LC below the cut-off value) and group B (LC above the cut-off value) for the endpoints according to receiver operating characteristic (ROC) analysis. The cumulative survival rate was 99% in group I-A and 85% in group I-B (p = 0.0004, log-rank test). The @entity712 -free survival rate was 95% in group II-A and 82% in group II-B (p = 0.0095, log-rank test). The re-MI-free survival rate did not differ between groups. A multivariate Cox analysis showed a statistically significant influence of LC on @entity204 [Hazard Ratio (HR): 1.41, 95% Confidence Interval (CI) (1.13-1.76), and p = 0.002] and @entity712 [HR: 1.21, 95% CI (1.05-1.4), and p = 0.007] with no impact on re-MI occurrence. LC in capillary blood may be considered a useful prognostic marker of late-onset @entity712 and @entity204 after @entity583 .

Handheld Capillary Blood @entity880 Analyzer as an Accessible and Cost-Effective Prognostic Tool for the Assessment of Death and XXXX Occurrence during Long-Term Follow-Up.

@entity1 :: ('9606', 'Species') :: ['patients'] @entity712 :: ('MESH:D006333', 'Disease') :: ['HF', 'heart failure'] @entity880 :: ('MESH:D019344', 'Chemical') :: ['lactate'] @entity583 :: ('MESH:D009203', 'Disease') :: ['AMI', 'myocardial infarction', 'acute myocardial infarction'] @entity204 :: ('MESH:D003643', 'Disease') :: ['death']
@entity712 :: (MESH:D006333,Disease) :: ['Heart Failure']
